{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:33:28Z","timestamp":1790037208456,"version":"4.0.1"},"reference-count":135,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP23ama221410"],"award-info":[{"award-number":["JP23ama221410"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP23ck0106793"],"award-info":[{"award-number":["JP23ck0106793"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP23fk0210131"],"award-info":[{"award-number":["JP23fk0210131"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>This review examines the latest epidemiological and molecular pathogenic findings of metabolic-associated hepatocellular carcinoma (HCC). Its increasing prevalence is a significant concern and reflects the growing burden of obesity and metabolic diseases, including metabolic dysfunction-associated steatotic liver disease, formerly known as nonalcoholic fatty liver disease, and type 2 diabetes. Metabolic-associated HCC has unique molecular abnormality and distinctive gene expression patterns implicating aberrations in bile acid, fatty acid metabolism, oxidative stress, and proinflammatory pathways. Furthermore, a notable frequency of single nucleotide polymorphisms in genes such as patatin-like phospholipase domain-containing 3, transmembrane 6 superfamily member 2, glucokinase regulator, and membrane-bound O-acyltransferase domain-containing 7 has been observed. The tumor immune microenvironment of metabolic-associated HCC is characterized by unique phenotypes of macrophages, neutrophils, and T lymphocytes. Additionally, the pathogenesis of metabolic-associated HCC is influenced by abnormal lipid metabolism, insulin resistance, and dysbiosis. In conclusion, deciphering the intricate interactions among metabolic processes, genetic predispositions, inflammatory responses, immune regulation, and microbial ecology is imperative for the development of novel therapeutic and preventative measures against metabolic-associated HCC.<\/jats:p>","DOI":"10.1055\/a-2289-2298","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T20:21:30Z","timestamp":1710793290000},"page":"147-158","source":"Crossref","is-referenced-by-count":13,"title":["Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma"],"prefix":"10.1055","volume":"44","author":[{"given":"Takahiro","family":"Kodama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Takehara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"J M Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"D Q Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"08","key":"ref4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"J M Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"M E Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","article-title":"Hepatokines and adipokines in NASH-related hepatocellular carcinoma","volume":"74","author":"O Kucukoglu","year":"2021","journal-title":"J Hepatol"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/hepr.14004","article-title":"New concept in fatty liver diseases","volume":"54","author":"K Tokushige","year":"2024","journal-title":"Hepatol Res"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"H Hagstr\u00f6m","year":"2024","journal-title":"J Hepatol"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"80","author":"S J Song","year":"2024","journal-title":"J Hepatol"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Q M Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical Bayesian approach","volume":"28","author":"M H Le","year":"2022","journal-title":"Clin Mol Hepatol"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Z M Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-1746.2008.05640.x","article-title":"Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C","volume":"24","author":"S Yatsuji","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Z Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"J Dyson","year":"2014","journal-title":"J Hepatol"},{"issue":"09","key":"ref16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/apt.14261","article-title":"Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period","volume":"46","author":"R Pais","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00535-018-1532-5","article-title":"A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update","volume":"54","author":"R Tateishi","year":"2019","journal-title":"J Gastroenterol"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis","volume":"128","author":"J Ertle","year":"2011","journal-title":"Int J Cancer"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jhep.2016.09.013","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection","volume":"66","author":"M Chayanupatkul","year":"2017","journal-title":"J Hepatol"},{"issue":"16","key":"ref20","first-page":"14","article-title":"Obesity management in the primary prevention of hepatocellular carcinoma","volume":"14","author":"E RM Zunica","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"25","key":"ref21","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. state-level prevalence of adult obesity and severe obesity","volume":"381","author":"Z J Ward","year":"2019","journal-title":"N Engl J Med"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"E J Park","year":"2010","journal-title":"Cell"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3350\/cmh.2020.0176","article-title":"Obesity and the risk of primary liver cancer: a systematic review and meta-analysis","volume":"27","author":"W Sohn","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2023.03.005","article-title":"Anthropometric indicators of adiposity and risk of primary liver cancer: a systematic review and dose-response meta-analysis","volume":"185","author":"L J Yan","year":"2023","journal-title":"Eur J Cancer"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.31014","article-title":"Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease","volume":"71","author":"F Kanwal","year":"2020","journal-title":"Hepatology"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"F Kanwal","year":"2018","journal-title":"Gastroenterology"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.gastro.2021.03.021","article-title":"Bariatric surgery reduces cancer risk in adults with nonalcoholic fatty liver disease and severe obesity","volume":"161","author":"V K Rustgi","year":"2021","journal-title":"Gastroenterology"},{"key":"ref28","first-page":"5202684","article-title":"Diabetes mellitus and risk of hepatocellular carcinoma","volume":"2017","author":"X Li","year":"2017","journal-title":"BioMed Res Int"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.30858","article-title":"Diabetes is associated with increased risk of hepatocellular carcinoma in patients with cirrhosis from nonalcoholic fatty liver disease","volume":"71","author":"J D Yang","year":"2020","journal-title":"Hepatology"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts","volume":"17","author":"M Alexander","year":"2019","journal-title":"BMC Med"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/cas.13582","article-title":"Molecular genomic landscapes of hepatobiliary cancer","volume":"109","author":"T Shibata","year":"2018","journal-title":"Cancer Sci"},{"issue":"03","key":"ref32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.gastro.2009.07.037","article-title":"Telomere dysfunction and DNA damage checkpoints in diseases and cancer of the gastrointestinal tract","volume":"137","author":"K L Rudolph","year":"2009","journal-title":"Gastroenterology"},{"issue":"06","key":"ref33","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.27372","article-title":"Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis","volume":"60","author":"J C Nault","year":"2014","journal-title":"Hepatology"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","article-title":"Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"75","author":"R Pinyol","year":"2021","journal-title":"J Hepatol"},{"issue":"04","key":"ref35","first-page":"132","article-title":"\u03b2-Catenin signaling in hepatocellular carcinoma","volume":"132","author":"C Xu","year":"2022","journal-title":"J Clin Invest"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"K Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma","volume":"169","author":"Cancer Genome Atlas Research Network","year":"2017","journal-title":"Cell"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.32573","article-title":"Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma","volume":"77","author":"H Murai","year":"2023","journal-title":"Hepatology"},{"issue":"04","key":"ref39","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"S BasuRay","year":"2017","journal-title":"Hepatology"},{"issue":"19","key":"ref40","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1073\/pnas.1901974116","article-title":"Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis","volume":"116","author":"S BasuRay","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort\u2606","volume":"73","author":"Q M Anstee","year":"2020","journal-title":"J Hepatol"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409\u2009C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Y L Liu","year":"2014","journal-title":"J Hepatol"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"J Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Y L Liu","year":"2014","journal-title":"Nat Commun"},{"issue":"06","key":"ref45","doi-asserted-by":"crossref","first-page":"e20555","DOI":"10.1371\/journal.pone.0020555","article-title":"Glucokinase regulatory protein genetic variant interacts with omega-3 PUFA to influence insulin resistance and inflammation in metabolic syndrome","volume":"6","author":"P Perez-Martinez","year":"2011","journal-title":"PLoS ONE"},{"issue":"22","key":"ref46","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1016\/j.cell.2022.09.031","article-title":"En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH","volume":"185","author":"M Kimura","year":"2022","journal-title":"Cell"},{"issue":"06","key":"ref47","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00535-013-0850-x","article-title":"Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene","volume":"49","author":"H L Tan","year":"2014","journal-title":"J Gastroenterol"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"e0185490","DOI":"10.1371\/journal.pone.0185490","article-title":"Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers","volume":"13","author":"T Kawaguchi","year":"2018","journal-title":"PLoS ONE"},{"issue":"05","key":"ref49","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"R M Mancina","year":"2016","journal-title":"Gastroenterology"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1038\/s41598-017-04991-0","article-title":"MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals","volume":"7","author":"B Donati","year":"2017","journal-title":"Sci Rep"},{"issue":"S 07","key":"ref51","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/cncr.31122","article-title":"High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease","volume":"124","author":"C G Tepper","year":"2018","journal-title":"Cancer"},{"issue":"21","key":"ref52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/nu14214556","article-title":"Race and ethnicity in non-alcoholic fatty liver disease (NAFLD): a narrative review","volume":"14","author":"K Riazi","year":"2022","journal-title":"Nutrients"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000800","article-title":"Genome-wide association study identifies high-impact susceptibility loci for hepatocellular carcinoma in North America","author":"M M Hassan","year":"2024","journal-title":"Hepatology"},{"issue":"14","key":"ref54","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3748\/wjg.v25.i14.1653","article-title":"Update on hepatocellular carcinoma: pathologists' review","volume":"25","author":"T El Jabbour","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"01","key":"ref55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.32542","article-title":"NAFLD-related hepatocellular carcinoma: the growing challenge","volume":"77","author":"P A Shah","year":"2023","journal-title":"Hepatology"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and liver cancer: molecular mechanisms and therapeutic targets","volume":"39","author":"Y M Yang","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver\u2013linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"T Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"01","key":"ref58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-\u03baB and STAT3 - key players in liver inflammation and cancer","volume":"21","author":"G He","year":"2011","journal-title":"Cell Res"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","article-title":"Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC","volume":"175","author":"M Grohmann","year":"2018","journal-title":"Cell"},{"issue":"12","key":"ref60","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.2337\/db17-0348","article-title":"JNK activation of BIM promotes hepatic oxidative stress, steatosis, and insulin resistance in obesity","volume":"66","author":"S A Litwak","year":"2017","journal-title":"Diabetes"},{"issue":"06","key":"ref61","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1101\/gad.1989311","article-title":"The role of JNK in the development of hepatocellular carcinoma","volume":"25","author":"M Das","year":"2011","journal-title":"Genes Dev"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/biomedicines10010083","article-title":"Intestinal barrier and permeability in health, obesity and NAFLD","volume":"10","author":"P Portincasa","year":"2021","journal-title":"Biomedicines"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2013from homeostasis to disease","volume":"13","author":"F Heymann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"06","key":"ref64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"S Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"03","key":"ref65","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"X Xiong","year":"2019","journal-title":"Mol Cell"},{"issue":"02","key":"ref66","doi-asserted-by":"crossref","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"S Daemen","year":"2021","journal-title":"Cell Rep"},{"issue":"06","key":"ref67","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","article-title":"Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis","volume":"52","author":"J S Seidman","year":"2020","journal-title":"Immunity"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"751802","DOI":"10.3389\/fendo.2021.751802","article-title":"Role of neutrophils in the pathogenesis of nonalcoholic steatohepatitis","volume":"12","author":"S Hwang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"04","key":"ref69","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"D J van der Windt","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"ref70","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"J Leslie","year":"2022","journal-title":"Gut"},{"issue":"06","key":"ref71","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"H Wang","year":"2021","journal-title":"J Hepatol"},{"issue":"02","key":"ref72","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment","volume":"200","author":"S Ostrand-Rosenberg","year":"2018","journal-title":"J Immunol"},{"issue":"07","key":"ref73","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41423-022-00872-3","article-title":"Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver","volume":"19","author":"W Tang","year":"2022","journal-title":"Cell Mol Immunol"},{"issue":"03","key":"ref74","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.26749","article-title":"Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH","volume":"59","author":"S Sutti","year":"2014","journal-title":"Hepatology"},{"issue":"12","key":"ref75","doi-asserted-by":"crossref","first-page":"G891","DOI":"10.1152\/ajpgi.00193.2013","article-title":"IFN-\u03b3 deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet","volume":"305","author":"X Y Luo","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"06","key":"ref76","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cmet.2021.04.018","article-title":"PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease","volume":"33","author":"M E Moreno-Fernandez","year":"2021","journal-title":"Cell Metab"},{"issue":"7593","key":"ref77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"C Ma","year":"2016","journal-title":"Nature"},{"issue":"01","key":"ref78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma","volume":"30","author":"A L Gomes","year":"2016","journal-title":"Cancer Cell"},{"issue":"7854","key":"ref79","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"M Dudek","year":"2021","journal-title":"Nature"},{"issue":"01","key":"ref80","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1038\/s41467-021-24734-0","article-title":"CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells","volume":"12","author":"Y Koda","year":"2021","journal-title":"Nat Commun"},{"issue":"7854","key":"ref81","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"D Pfister","year":"2021","journal-title":"Nature"},{"issue":"7680","key":"ref82","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"S Shalapour","year":"2017","journal-title":"Nature"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2018.06.015","article-title":"B2-lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)","volume":"124","author":"S Bruzz\u00ec","year":"2018","journal-title":"Free Radic Biol Med"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"F Barrow","year":"2021","journal-title":"Hepatology"},{"issue":"06","key":"ref85","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/hep.27761","article-title":"Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity","volume":"61","author":"M Thapa","year":"2015","journal-title":"Hepatology"},{"issue":"11","key":"ref86","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1172\/JCI24798","article-title":"Attenuated liver fibrosis in the absence of B cells","volume":"115","author":"T I Novobrantseva","year":"2005","journal-title":"J Clin Invest"},{"issue":"05","key":"ref87","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1002\/hep.29636","article-title":"B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury","volume":"67","author":"F Faggioli","year":"2018","journal-title":"Hepatology"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"596318","DOI":"10.3389\/fonc.2020.596318","article-title":"Single-cell RNA-seq analysis reveals microenvironmental infiltration of plasma cells and hepatocytic prognostic markers in HCC with cirrhosis","volume":"10","author":"S Zhang","year":"2020","journal-title":"Front Oncol"},{"issue":"03","key":"ref89","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate","volume":"21","author":"P S Ward","year":"2012","journal-title":"Cancer Cell"},{"issue":"01","key":"ref90","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/cancers10010003","article-title":"Lipid metabolism and lipid droplets in pancreatic cancer and stellate cells","volume":"10","author":"Y Sunami","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"05","key":"ref91","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1053\/j.gastro.2013.01.054","article-title":"Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes","volume":"144","author":"A Budhu","year":"2013","journal-title":"Gastroenterology"},{"issue":"18","key":"ref92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms21186799","article-title":"NASH, fibrosis and hepatocellular carcinoma: lipid synthesis and glutamine\/acetate signaling","volume":"21","author":"Y Sunami","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"02","key":"ref93","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2023.10.042","article-title":"Pharmacologic inhibition of lipogenesis for the treatment of NAFLD","volume":"80","author":"W P Esler","year":"2024","journal-title":"J Hepatol"},{"issue":"03","key":"ref94","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"J E Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2019.12.010","article-title":"ATP citrate lyase: a central metabolic enzyme in cancer","volume":"471","author":"P Icard","year":"2020","journal-title":"Cancer Lett"},{"issue":"06","key":"ref96","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1242\/dmm.011338","article-title":"Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development","volume":"6","author":"F Baenke","year":"2013","journal-title":"Dis Model Mech"},{"issue":"03","key":"ref97","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.gastro.2010.12.006","article-title":"Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma","volume":"140","author":"D F Calvisi","year":"2011","journal-title":"Gastroenterology"},{"issue":"02","key":"ref98","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2015.10.004","article-title":"Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans","volume":"64","author":"L Li","year":"2016","journal-title":"J Hepatol"},{"issue":"01","key":"ref99","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","article-title":"Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans","volume":"69","author":"L Che","year":"2020","journal-title":"Gut"},{"issue":"01","key":"ref100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cmet.2018.08.020","article-title":"Inhibition of Acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma","volume":"29","author":"J SV Lally","year":"2019","journal-title":"Cell Metab"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000513","article-title":"Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making","author":"R Dhanasekaran","year":"2023","journal-title":"Hepatology"},{"issue":"01","key":"ref102","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/db08-1074","article-title":"Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver","volume":"58","author":"A Kotronen","year":"2009","journal-title":"Diabetes"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jhep.2008.07.036","article-title":"Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma","volume":"50","author":"T Yamashita","year":"2009","journal-title":"J Hepatol"},{"issue":"05","key":"ref104","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.3390\/ijms15057124","article-title":"SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma","volume":"15","author":"C Li","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"06","key":"ref105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41574-023-00809-4","article-title":"The role of ChREBP in carbohydrate sensing and NAFLD development","volume":"19","author":"M R\u00e9gnier","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"05","key":"ref106","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s12276-020-0430-0","article-title":"The cellular function of SCAP in metabolic signaling","volume":"52","author":"S H Lee","year":"2020","journal-title":"Exp Mol Med"},{"issue":"11","key":"ref107","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1172\/JCI151895","article-title":"Inhibiting SCAP\/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis","volume":"132","author":"S Kawamura","year":"2022","journal-title":"J Clin Invest"},{"issue":"07","key":"ref108","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.metabol.2010.10.003","article-title":"Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis","volume":"60","author":"L Zhu","year":"2011","journal-title":"Metabolism"},{"issue":"05","key":"ref109","doi-asserted-by":"crossref","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human NAFLD","volume":"294","author":"D Greco","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"14752","DOI":"10.1038\/srep14752","article-title":"Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"5","author":"A Nath","year":"2015","journal-title":"Sci Rep"},{"issue":"11","key":"ref111","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"J Westerbacka","year":"2007","journal-title":"Diabetes"},{"issue":"06","key":"ref112","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3892\/etm.2011.328","article-title":"Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease","volume":"2","author":"N Higuchi","year":"2011","journal-title":"Exp Ther Med"},{"issue":"7400","key":"ref113","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature11066","article-title":"AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress","volume":"485","author":"S M Jeon","year":"2012","journal-title":"Nature"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"15838","DOI":"10.1038\/srep15838","article-title":"CCAAT\/enhancer-binding protein \u03b1 is required for hepatic outgrowth via the p53 pathway in zebrafish","volume":"5","author":"H Yuan","year":"2015","journal-title":"Sci Rep"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"970292","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"C Fang","year":"2022","journal-title":"Front Physiol"},{"issue":"01","key":"ref116","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2018.05.005","article-title":"Cancer lipid metabolism confers antiangiogenic drug resistance","volume":"28","author":"H Iwamoto","year":"2018","journal-title":"Cell Metab"},{"issue":"06","key":"ref117","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.celrep.2014.08.028","article-title":"HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression","volume":"8","author":"D Huang","year":"2014","journal-title":"Cell Rep"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"35784","DOI":"10.1038\/srep35784","article-title":"Monoacylglycerol lipase: a novel potential therapeutic target and prognostic indicator for hepatocellular carcinoma","volume":"6","author":"J Zhang","year":"2016","journal-title":"Sci Rep"},{"issue":"01","key":"ref119","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/liv.13183","article-title":"Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells","volume":"37","author":"D Cao","year":"2017","journal-title":"Liver Int"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"944088","DOI":"10.3389\/fphar.2022.944088","article-title":"The pathogenesis of HCC driven by NASH and the preventive and therapeutic effects of natural products","volume":"13","author":"G Shao","year":"2022","journal-title":"Front Pharmacol"},{"issue":"03","key":"ref121","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/hep.510260310","article-title":"Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes","volume":"26","author":"S Tanaka","year":"1997","journal-title":"Hepatology"},{"issue":"05","key":"ref122","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/cancers12051290","article-title":"Molecular mechanisms regulating obesity-associated hepatocellular carcinoma","volume":"12","author":"Y Rajesh","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"02","key":"ref123","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/hep.32317","article-title":"TNF receptor-related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-\u03baB-inducing kinase-mediated hepatocyte transdifferentiation","volume":"77","author":"Y Shiode","year":"2023","journal-title":"Hepatology"},{"issue":"44","key":"ref124","doi-asserted-by":"crossref","first-page":"E10417","DOI":"10.1073\/pnas.1808968115","article-title":"Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis","volume":"115","author":"T Kodama","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"ref125","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology","volume":"13","author":"H Shimano","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"03","key":"ref126","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"C Postic","year":"2008","journal-title":"J Clin Invest"},{"issue":"06","key":"ref127","first-page":"801","article-title":"Impact of insulin resistance on the progression of chronic liver diseases","volume":"22","author":"K Kaji","year":"2008","journal-title":"Int J Mol Med"},{"issue":"01","key":"ref128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12885-023-10561-7","article-title":"IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K\/akt and RAS\/raf\/ERK signaling pathways","volume":"23","author":"W Cai","year":"2023","journal-title":"BMC Cancer"},{"issue":"7999","key":"ref129","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-023-06991-9","article-title":"Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver","volume":"626","author":"W Fan","year":"2024","journal-title":"Nature"},{"issue":"01","key":"ref130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"F R Ponziani","year":"2019","journal-title":"Hepatology"},{"issue":"07","key":"ref131","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4254\/wjh.v14.i7.1277","article-title":"Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis","volume":"14","author":"V Liakina","year":"2022","journal-title":"World J Hepatol"},{"issue":"7456","key":"ref132","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"S Yoshimoto","year":"2013","journal-title":"Nature"},{"issue":"72","key":"ref133","doi-asserted-by":"crossref","first-page":"eabl7209","DOI":"10.1126\/sciimmunol.abl7209","article-title":"Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma","volume":"7","author":"R Yamagishi","year":"2022","journal-title":"Sci Immunol"},{"issue":"05","key":"ref134","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","article-title":"Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity","volume":"7","author":"T M Loo","year":"2017","journal-title":"Cancer Discov"},{"issue":"02","key":"ref135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2008.08.096","article-title":"Role of TLR9 in hepatic stellate cells and experimental liver fibrosis","volume":"376","author":"E G\u00e4bele","year":"2008","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2289-2298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T05:47:55Z","timestamp":1730785675000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2289-2298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":135,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,7,12]]},"published-print":{"date-parts":[[2024,5]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2289-2298","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,18]]},"published":{"date-parts":[[2024,3,18]]}}}